Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 5/20 | 0.42 |
| ▸ | ADH1C | P00326 | 4/20 | 0.42 |
| ▸ | ADH1B | P00325 | 3/20 | 0.42 |
| ▸ | ADH4 | P08319 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.39 |
| ▸ | ADH7 | P40394 | 1/20 | 0.38 |
| ▸ | SHBG | P04278 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | GMNN | O75496 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8794444 | 0.84 | — | — | |
| SCHEMBL1702118 | 0.81 | CPN1 (0.34) | ADH1AADH1CADH1BADH4EPHX1 | |
| SCHEMBL11220305 | 0.73 | ADH1A (0.39) | ADH1AADH1CADH1BADH4EPHX1 | |
| SCHEMBL5646568 | 0.72 | EPHX1 (0.41) | ADH1AADH1CADH1BADH4EPHX1 | |
| SCHEMBL21114321 | 0.72 | ADH1A (0.41) | ADH1AADH1CADH1BADH4EPHX1 | |
| SCHEMBL11225403 | 0.72 | ADH1A (0.39) | ADH1AADH1CADH1BADH4EPHX1 | |
| SCHEMBL21114287 | 0.72 | ADH1A (0.41) | ADH1AADH1CADH1BADH4EPHX1 | |
| SCHEMBL22081103 | 0.72 | EPHX1 (0.41) | ADH1AADH1CADH1BADH4EPHX1 | |
| SCHEMBL21114234 | 0.72 | ADH1A (0.41) | ADH1AADH1CADH1BADH4EPHX1 | |
| SCHEMBL5275950 | 0.72 | ADH1A (0.39) | ADH1AADH1CADH1BADH4EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103086848-B | Dicyclohexylalkyl ether terminal olefines liquid crystal compound and preparation method thereof | YANTAI DERUN LIQUID CRYSTAL MATERIALS CO LTD | 2014-09-03 | — | — | CN | claimed |
| CN-103086848-A | Dicyclohexylalkyl ether terminal olefines liquid crystal compound and preparation method thereof | YANTAI DERUN LIQUID CRYSTAL MATERIALS CO LTD | 2013-05-08 | — | — | CN | claimed |
| CN-119118864-A | RXFP1 receptor agonist and preparation method and medical application thereof | 深圳信立泰药业股份有限公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-118619931-A | Aryl or heteroaryl derivative inhibitor, preparation method and application thereof | 上海翰森生物医药科技有限公司 | 2024-09-10 | — | — | CN | disclosed |
| CN-118317962-A | Imidazopyridazine IL-17 inhibitor compounds | 詹森药业有限公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-114585628-B | Modulators of cystic fibrosis transmembrane conductance regulator | 弗特克斯药品有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-111295382-B | Bridged bicyclic compounds as farnesyl ester X receptor modulators | 百时美施贵宝公司 | 2024-02-02 | — | — | CN | disclosed |
| CN-117285547-A | Macrocyclic compounds as modulators of CFTR, pharmaceutical compositions thereof, their use and methods of preparation | 弗特克斯药品有限公司 | 2023-12-26 | — | — | CN | disclosed |
| CN-111278821-B | Spiro compounds as farnesol X receptor modulators | 百时美施贵宝公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-116583521-A | Imidazopyridazine derivatives as IL-17 modulators | UCB生物制药有限责任公司 | 2023-08-11 | — | — | CN | disclosed |
| CN-116406267-A | Bicyclic propyl methyl derivatives as IL-17 modulators | UCB生物制药有限责任公司 | 2023-07-07 | — | — | CN | disclosed |
| EP-1178969-A1 | GASTRIN AND CHOLECYSTOKININ RECEPTOR LIGANDS | JAMES BLACK FOUNDATION LIMITED (GB) | 2002-02-13 | — | — | EP | disclosed |
| CN-1325385-A | Gastrin and cholecystokinin receptor ligands | BLACK JAMES FOUNDATION (GB) | 2001-12-05 | — | — | CN | disclosed |
| EP-0637623-B1 | Cyclic hydrocarbon derivative and liquid crystal composition containing the same | DAINIPPON INK & CHEMICALS (JP) | 2001-10-04 | — | — | EP | disclosed |
| WO-2000027823-A1 | GASTRIN AND CHOLECYSTOKININ RECEPTOR LIGANDS | JAMES BLACK FOUNDATION LIMITED (GB) | 2000-05-18 | — | — | WO | disclosed |
| EP-1000924-A1 | ACID-SENSITIVE COMPOUND AND RESIN COMPOSITION FOR PHOTORESIST | Daichel Chemical Industries Ltd (JP) | 2000-05-17 | — | — | EP | disclosed |
| US-5536443-A | DUTERIUM CONTAINING COMPOUNDS FOOR ELECTROOPTICAL APPARATUS | DAINIPPON INK & CHEMICALS, INC. (JP) | 1996-07-16 | — | — | US | disclosed |
| US-5474707-A | Electrooptic display | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1995-12-12 | — | — | US | disclosed |
| EP-0637623-A1 | Cyclic hydrocarbon derivative and liquid crystal composition containing the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1995-02-08 | — | — | EP | disclosed |
| US-4370323-A | 2-Cyanoaziridinyl-(1)-2-substituted-aziridinyl-(1)-methanes | BOEHRINGER MANNHEIM GMBH (DE) | 1983-01-25 | — | — | US | disclosed |